Also trades as: HBP.TO (TSX) · $vol 0M
HBPCF OTC
Helix BioPharma Corp.
1W: -55.0%
1M: -55.0%
3M: -55.0%
YTD: -55.5%
1Y: +28.3%
3Y: +6.2%
5Y: -75.2%
$0.77
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$4M
+23.4% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$4M
+23.6% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$1M
-466.3% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$8M | -$7M | -$6M | -$9M | -$5M |
| Depreciation & Amort. | $199K | $12K | $13K | $14K | $10K |
| Stock-Based Comp. | $663K | $425K | $569K | $4M | $0 |
| Change in Working Capital | -$54K | -$892K | $186K | $485K | $1M |
| Other Non-Cash Items | $142K | $500K | -$5K | $31K | $31K |
| Operating Cash Flow | -$9M | -$7M | -$6M | -$5M | -$4M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | -$10K | -$14K | $0 |
| Acquisitions (Net) | $2M | $0 | $5K | $0 | $19K |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $2K | $0 | $5K | $0 | $0 |
| Investing Cash Flow | $2M | $0 | -$5K | -$14K | $17K |
| — Financing Activities — | |||||
| Net Debt Issuance | $3M | $0 | -$2M | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $4M | $3M | $5M | $0 | $0 |
| Financing Cash Flow | $7M | $6M | $3M | $6M | $3M |
| Net Change in Cash | -$670K | -$313K | -$2M | $273K | -$1M |
| Cash End of Period | $4M | $3M | $808K | $1M | $65K |
| Free Cash Flow | -$9M | -$7M | -$6M | -$5M | -$4M |